
|Articles|February 1, 2008
Physicians regroup, prep strategies during fee reprieve
Urologists and other physicians who treat Medicare patients have been given a short reprieve from the across-the-board 10.1% reimbursement cut that was scheduled for Jan. 1, and have even received a little bit of a raise.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves tebipenem pivoxil for complicated urinary tract infections
2
Behind the FDA approval of capivasertib for mHSPC, with Daniel J. George, MD
3
The ArteraAI Prostate Test: What It Is and How It Works
4
FDA gives nod to feasibility study of NanoKnife IRE for benign prostatic hyperplasia
5











